Related Experiment Video
Updated: Jun 8, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Bladder cancer: a review of clinical management and prognostic factors
T Patel1, M Pitman, J M McKiernan
1Department of Urology, Columbia University College of Physicians and Surgeons, New York, NY, USA. tp2200@columbia.edu
Abstract:
Bladder cancer is a heterogeneous disease that offers a unique challenge for the patient and the physician as treatment paradigms are continually evolving. There are multiple factors that can influence how each individual is treated, including lymphovascular invasion, micropapillary histology, and p53 nuclear accumulation which have demonstrated a worse prognosis in patients with bladder cancer. They can influence the use of neoadjuvant and adjuvant chemotherapy, which in itself can affect the timing of extirpative surgery. This review will focus on the contemporary management and treatment of bladder cancer focusing on areas of clinical decision making.
Related Concept Videos
Urinary Tract Calculi V: Nursing Management
Urinary Tract Calculi III: Medical Management
Cancer Survival Analysis
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Infection IV: Nursing Management

